[Spophylin Spofa--tablets with a delayed effect: therapeutic use in the complex therapy of acute bronchitis in infants and toddlers].
In 18 children aged 6-36 months with acute respiratory disease and bronchospasms the authors administered as part of comprehensive treatment Spophyllin tablets with a retarded effect (16-20 mg/kg/hours). Concurrently the theophyllin serum and saliva levels were assessed on the third day of administration. The authors proved a direct relationship between serum and saliva levels. The assessed values in saliva accounted on average for 73.5% of the serum levels. Values in saliva (6-7 micrograms/l ml) were indicators of effective serum values.
Michalicková
J
J
Centrum pre výskum zdravia zeny a diet'at'a--oddelenie výskumu zdravia diet'at'a pri Vyskumnom ústave lekárskej bioniky, Bratislava.
Sulko
M
M
D000208:Acute Disease; D001991:Bronchitis / Q000188:drug therapy*; D002675:Child, Preschool; D003692:Delayed-Action Preparations; D006801:Humans; D007223:Infant; D013607:Tablets; D013806:Theophylline / Q000008:administration & dosage* / Q000627:therapeutic use
D003692:Delayed-Action Preparations; D013607:Tablets; D013806:Theophylline
Spophylin Spofa--tabletky s retardovaným úcinkom: terapeutické vyuzitie v komplexnej liecbe akútnych bronchitíd kojencov a batoliat.